C

Catalyst Pharmaceuticals
D

CPRX

22.870
USD
-0.03
(-0.13%)
مغلق
حجم التداول
14,742
الربح لكل سهم
2
العائد الربحي
-
P/E
19
حجم السوق
2,727,783,481
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Catalyst Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.